SCHEMBL31455449

SCHEMBL31455449

COC(=O)C1CCC(C(=O)Nc2ccc(Nc3nc(-c4ccccc4)ccc3[N+](=O)[O-])c(C)c2F)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.39
GSK3A P49840 2/20 0.39
ADORA1 P30542 7/20 0.38
ADORA3 P0DMS8 6/20 0.38
ADORA2A P29274 5/20 0.38
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ABCB1 P08183 1/20 0.34
NPC1 O15118 1/20 0.34
ABL1 P00519 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455145 0.91 CYP3A4 (0.33) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455361 0.86 ADORA1 (0.40) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455694 0.86 HDAC1 (0.46) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455411 0.86 HDAC1 (0.46) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455204 0.83 GSK3B (0.38) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455294 0.80 BRD9 (0.41) HTTTDP1NPC1ALDH1A1MAPT
SCHEMBL31455019 0.79 GSK3A (0.34) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455406 0.78 CYP3A4 (0.34) GSK3BGSK3AADORA1ADORA3ADORA2A
SCHEMBL31455141 0.78 POLB (0.36) KDM4EHTTABCB1NPC1ALDH1A1
SCHEMBL31455503 0.76 ABCG2 (0.38) GSK3BHTTTDP1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed